{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:59:11Z","timestamp":1787237951625,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.ejim.2014.04.004","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T00:30:14Z","timestamp":1398731414000},"page":"506-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Is it time to change the neurofibromatosis 1 diagnostic criteria?"],"prefix":"10.1016","volume":"25","author":[{"given":"Gianluca","family":"Tadini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Menni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Pezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Sabatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2014.04.004_bb0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1988.00520290115023","article-title":"Neurofibromatosis","volume":"45","author":"National Institutes of Health Consensus Development Conference Statement","year":"1988","journal-title":"Arch Neurol (Chic)"},{"key":"10.1016\/j.ejim.2014.04.004_bb0010","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/humu.22392","article-title":"NF1 molecular characterization and neurofibromatosis type 1 genotype\u2013phenotype correlation: the French experience","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ejim.2014.04.004_bb0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.ejim.2014.04.004_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2006.00639.x","article-title":"Neurofibromin: a general outlook","volume":"70","author":"Trov\u00f3-Marqui","year":"2006","journal-title":"Clin Genet"},{"key":"10.1016\/j.ejim.2014.04.004_bb0025","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/humu.21271","article-title":"NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype","volume":"31","author":"Pasmant","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ejim.2014.04.004_bb0030","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970\u20132972 delAAT): evidence of a clinically significant NF1 genotype\u2013phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ejim.2014.04.004_bb0035","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/jmedgenet-2013-101648","article-title":"Can the diagnosis of NF1 be excluded clinically? A lack of pigmentary findings in families with spinal neurofibromatosis demonstrates a limitation of clinical diagnosis","volume":"50","author":"Burkitt Wright","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.ejim.2014.04.004_bb0040","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejim.2014.04.004_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000327379","article-title":"Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients","volume":"222","author":"Duong","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.ejim.2014.04.004_bb0050","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ajpath.2010.12.056","article-title":"The pathoetiology of neurofibromatosis 1","volume":"178","author":"Jouhilahti","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1203\/PDR.0b013e31817445b8","article-title":"Schwann cells from human neurofibromas show increased proliferation rates under the influence of progesterone","volume":"64","author":"Overdiek","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ejim.2014.04.004_bb0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1600-0560.2010.01529.x","article-title":"Cutaneous plexiform lesions","volume":"37","author":"Abbas","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0070","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.0736-8046.2004.21201.x","article-title":"Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies","volume":"21","author":"Cambiaghi","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pbc.22297","article-title":"Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia","volume":"54","author":"Raygada","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejim.2014.04.004_bb0080","first-page":"180","article-title":"Blue\u2013red macules and pseudoatrophic macules in neurofibromatosis 1","volume":"129","author":"Zeller","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0085","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1093\/hmg\/ddl165","article-title":"Nf1+\/\u2212mast cells induce neurofibroma like phenotypes through secreted TGF-\u03b2 signaling","volume":"15","author":"Yang","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ejim.2014.04.004_bb0090","doi-asserted-by":"crossref","first-page":"7393","DOI":"10.1158\/0008-5472.CAN-09-1752","article-title":"Glomus tumors in neurofibromatosis type 1: genetic, functional and clinical evidence of a novel association","volume":"69","author":"Brems","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejim.2014.04.004_bb0095","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000346643","article-title":"Anemic nevus in neurofibromatosis type 1","volume":"226","author":"Tadini","year":"2013","journal-title":"Dermatology"},{"key":"10.1016\/j.ejim.2014.04.004_bb0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/eye.1993.20","article-title":"Images of Lisch nodules across the spectrum","volume":"7","author":"Ragge","year":"1993","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ejim.2014.04.004_bb0105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/13816819109023079","article-title":"Structure of Lisch nodules in neurofibromatosis type 1","volume":"12","author":"Williamson","year":"1991","journal-title":"Ophthalmic Paediatr Genet"},{"key":"10.1016\/j.ejim.2014.04.004_bb0110","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ophtha.2011.07.046","article-title":"Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1","volume":"119","author":"Viola","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejim.2014.04.004_bb0115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WNO.0b013e31822aef82","article-title":"Optic pathway gliomas","volume":"31","author":"Avery","year":"2011","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ana.21107","article-title":"Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations","volume":"61","author":"Listernick","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-012-0944-y","article-title":"Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research","volume":"110","author":"Avery","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0130","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00431-013-2035-2","article-title":"Ophthalmological assessment of children with neurofibromatosis type 1","volume":"172","author":"Cassiman","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ejim.2014.04.004_bb0135","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/ajmg.a.36001","article-title":"The generalized bone phenotype in children with neurofibromatosis 1: a sibling matched case\u2013control study","volume":"161","author":"Armstrong","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2014.04.004_bb0140","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3171\/2013.1.PEDS12409","article-title":"Calvarial defects and skeletal dysplasia in patients with neurofibromatosis type 1","volume":"11","author":"Arrington","year":"2013","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.ejim.2014.04.004_bb0145","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1542\/peds.103.6.1257","article-title":"Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study","volume":"103","author":"Carmi","year":"1999","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejim.2014.04.004_bb0150","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jpeds.2006.10.048","article-title":"Bone mineral density in children and adolescents with neurofibromatosis type 1","volume":"150","author":"Sheng","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.ejim.2014.04.004_bb0155","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1515\/jpem.2011.092","article-title":"Pediatric 25-hydroxyvitamin D concentrations in neurofibromatosis type 1","volume":"24","author":"Stevenson","year":"2011","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ejim.2014.04.004_bb0160","first-page":"111","article-title":"Vitamin D status and muscle function in children with neurofibromatosis type 1 (NF1)","volume":"13","author":"Hockett","year":"2013","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/j.ejim.2014.04.004_bb0165","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0","article-title":"Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1","volume":"95","author":"Lin","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ejim.2014.04.004_bb0170","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jvs.2007.03.055","article-title":"Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results","volume":"46","author":"Oderich","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejim.2014.04.004_bb0175","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jvs.2004.12.021","article-title":"Renal artery stenosis and aneurysms associated with neurofibromatosis","volume":"41","author":"Han","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.ejim.2014.04.004_bb0180","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00330-006-0323-1","article-title":"Magnetization transfer ratio and volumetric analysis of the brain in macrocephalic patients with neurofibromatosis type 1","volume":"17","author":"Margariti","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0185","first-page":"810","article-title":"Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities","volume":"22","author":"Steen","year":"2001","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0190","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.1523\/JNEUROSCI.3242-12.2012","article-title":"Neurofibromatosis type 1: modeling CNS dysfunction","volume":"32","author":"Gutmann","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.ejim.2014.04.004_bb0195","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1212\/WNL.54.8.1646","article-title":"Use of \u201cunidentified bright objects\u201d on MRI for diagnosis of neurofibromatosis 1 in children","volume":"54","author":"DeBella","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2014.04.004_bb0200","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000355417","article-title":"Diffuse pontine lesions in children with neurofibromatosis type 1: making a case for unidentified bright objects","volume":"49","author":"Hervey-Jumper","year":"2013","journal-title":"Pediatr Neurosurg"},{"key":"10.1016\/j.ejim.2014.04.004_bb0205","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1111\/epi.12348","article-title":"Epilepsy in individuals with neurofibromatosis type 1","volume":"54","author":"Ostendorf","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejim.2014.04.004_bb0210","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.seizure.2011.04.016","article-title":"Epileptic seizures in neurofibromatosis type 1 are related to intracranial tumors but not to neurofibromatosis bright objects","volume":"20","author":"Hsieh","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.ejim.2014.04.004_bb0215","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/brain\/122.3.473","article-title":"Neurological complications of neurofibromatosis type 1 in adulthood","volume":"122","author":"Cr\u00e9ange","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.ejim.2014.04.004_bb0220","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s10072-013-1403-z","article-title":"Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type 1","volume":"34","author":"Carotenuto","year":"2013","journal-title":"Neurol Sci"},{"key":"10.1016\/j.ejim.2014.04.004_bb0225","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ejim.2014.04.004_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1469-8749.2012.04399.x","article-title":"Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence","volume":"55","author":"Lehtonen","year":"2013","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0235","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004703-199608000-00004","article-title":"Children and adolescents with neurofibromatosis 1: a behavioral phenotype","volume":"17","author":"Dilts","year":"1996","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.ejim.2014.04.004_bb0240","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/0883073808316366","article-title":"Impact of neurofibromatosis type 1 on school performance","volume":"23","author":"Krab","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ejim.2014.04.004_bb0245","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1542\/peds.2013-1868","article-title":"Neurofibromatosis type 1 and autism spectrum disorder","volume":"132","author":"Garg","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejim.2014.04.004_bb0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1634\/theoncologist.2010-0181","article-title":"Neoplasms associated with germline and somatic NF1 gene mutations","volume":"17","author":"Patil","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.ejim.2014.04.004_bb0255","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study","volume":"108","author":"Seminog","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejim.2014.04.004_bb0260","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/ajmg.a.35982","article-title":"Healthcare transition in patients with rare genetic disorders with and without developmental disability: neurofibromatosis 1 and Williams\u2013Beuren syndrome","volume":"161A","author":"Van Lierde","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2014.04.004_bb0265","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000357137","article-title":"Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors","volume":"86","author":"Lamm","year":"2014","journal-title":"Oncology"},{"key":"10.1016\/j.ejim.2014.04.004_bb0270","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000337548","article-title":"Psychological burden in adult neurofibromatosis type 1 patients: impact of disease visibility on body image","volume":"224","author":"Granstrom","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.ejim.2014.04.004_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.36466","article-title":"Relationship between whole-body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis","author":"Merker","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ejim.2014.04.004_bb0280","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ejhg.2011.113","article-title":"Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989","volume":"19","author":"Evans","year":"2011","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ejim.2014.04.004_bb0285","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ajmg.a.36312","article-title":"CTF meeting 2012: translation of the basic understanding of the biology and genetics of NF1, NF2, and schwannomatosis toward the development of effective therapies","volume":"164","author":"Widemann","year":"2014","journal-title":"Am J Med Genet A"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514001083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620514001083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T19:41:31Z","timestamp":1565379691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620514001083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0953620514001083"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2014.04.004","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is it time to change the neurofibromatosis 1 diagnostic criteria?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2014.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}